IT-1208 (Kyowa Hakko Kirin)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIT-1208 (Kyowa Hakko Kirin)
Drug Alias NameIT-1208
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionT-cell surface antigen CD4 inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Hakko Kirin Co LtdOno Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A